Global Bio-implant Market by Material (Polymers, Alloys, Biomaterial Metal, Ceramics), by Product (Spinal, Dental, Cardiovascular) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Summary of the Report

Global bio-implant market was valued at USD 65.0 million in 2018. It will grow by 5.9% over the forecast period. The market is driven by the rising popularity of bio-implant therapies over other therapy treatments like physiotherapy and arthroscopy. The market's preference for bio-implant procedures is due to their higher success rate and biocompatibility. The market is also being driven by increasing incidence of orthopedic and cardiovascular ailments, large geriatric populations, lifestyle changes and increased adoption of cosmetic surgery.

Market growth is also driven by increasing awareness of cosmetic implants and advances in bioengineering technology. Many medical specialties are seeing a rise in demand for bio-implants that are non-surgical and minimally invasive. Bio-implants are being used by more dental patients as an alternative to root canal procedures. Bio-implants will be more in demand as a result of the alarming rise in dental healthcare issues. According to the WHO's Global Burden of Disease Study 2016 (GBDS), approximately half of all people worldwide are affected by oral diseases. Dental caries and other tooth problems were affecting nearly 3.58 billion people. This will allow for a larger market.

Many chronic diseases such as CVD, congenital, neuropathic, and osteoarthritis are caused by sedentary lifestyles. This has fueled the worldwide demand for bio-implants. According to the National Spinal Cord Injury Statistics Center, 54.0% of Americans were suffering from spinal cord injuries in 2016. These cases are expected to impact almost 60% of the U.S. populace by 2020, which will create growth opportunities for this market.

The biocompatibility and biocompatibility have been greatly enhanced by technological advances in the manufacturing of bio-implants such as 3D printing, laser technology and nanotechnology. This is supported strongly by the rise in funding for healthcare by governments all over the globe. Many government agencies are collaborating with manufacturing and healthcare research companies to bring more efficient devices to the market. In June 2019, for instance, the Government of Kazakhstan expressed interest in partnering with MIDHANI (an Indian manufacturer of bio-implants) to produce commercial-scale titanium bio-implants.

Product Insights

Orthopedic implants held the top spot in 2018 based on product. The leading share in 2018 was accounted for by orthopedic implants. This is due to the rising use of orthopedic surgery, increasing incidence of orthotic diseases and favorable reimbursement policies from various governments. The Centers for Disease Control and Prevention reported that arthritis affected nearly 54.4 million Americans in 2017.

However, the growth rate of dental implants is expected to be higher during the forecast period. This is due to factors like an aging population with more severe tooth defects and a growing demand for cosmetic and dental surgery. In 2017, the American Academy of Implant Dentistry reported that more than 69.0% of Americans aged 35-44 had one missing tooth. In the future, dental problems will likely increase due to a more sedentary lifestyle as well as increased nicotine and tobacco use. This will impact the overall demand for dental bio-implants.

Material Insights

The biomaterial metal segment held the largest market share in 2018, and will continue to do so over the forecast period. This segment is expected to grow due to its associated advantages, such as greater tensile strength and resistance to corrosion, as opposed to other materials like alloys or ceramics. Biomaterial metals are used in dental implants, joint replacement implants, pacemaker cases, and other applications.

Ceramic implants will grow at a rapid pace during the forecast period. Ceramics are gaining much attention due to their ability deliver the necessary mechanical function for tissue rehabilitation. Bio-ceramics are expected to be more popular in the future, due to their ability to stimulate bone regeneration tissue.

Origin Insights

Xenografts held the largest market share on the basis of origin in 2018. This is mainly due to their biological origin which makes them more compatible and adaptable with the human body. Allografts, on the other hand are expected to grow faster during the forecast period. This can be attributed to the benefits of a lower risk of harvest site morbidity and reduced postoperative pain. It also means that there is less time for recovery and surgical time. LifeLink Tissue Bank's 2018 data shows that over 1.7 million allografts were implanted annually in the U.S. These grafts can be used in nearly all types of surgery such as orthopaedic, gynecology and cardiac surgery.

End-use Insights

The market can be divided into three segments based on its end use: hospitals, clinics and specialty centers. In 2018, hospitals held the largest market share and they will continue to hold that position throughout the forecast period. This is due to the large patient base and favorable reimbursement policies for expensive implants such as pacemakers in government hospitals. The second highest revenue share was held by clinics in 2018, and they will continue to grow through 2026.

In recent years, however, specialty centers have been more popular for treating various orthopedic and cardiac diseases. This is due to increasing awareness of different conditions and the various treatment options available as well as an increase in disposable income. Because these centers are tailored to specific medical conditions, they contribute to better clinical outcomes and lower costs. These factors will drive the segment's growth over the forecast period.

Regional Insights

North America is anticipated to dominate the global market owing to factors such as increasing number of surgical procedures needing implants and rising adoption of advanced technologies across various medical disciplines.According to the Organisation for Economic Co-operation and Development (OECD) Health Statistics, more than 1.4 million orthopedic procedures were conducted in 2017, including hip and knee replacement surgeries, which is poised to grow in the near future. This will likely benefit regional growth.

Europe is the second-largest market for bio-implants. This is due to a growing number of orthopedic disorders and government funding. Many pacemaker makers are currently working to develop MRI-conditional pacemakers and leadless pacemakers. Market growth is also being driven by the increasing prevalence of CVD surgery.

Asia Pacific will be the fastest-growing region over the forecast period. This is primarily due to the high incidence of spinal cord injury. Road accidents are a major reason for this. According to Tokyo's Keio University, Japan's spinal cord injuries have left more than 100,000 people paralysed. The country's recent approval of iPS technology is expected to aid such patients in coming years, opening up new markets for bio-implants.

Market Share Insights & Key Companies

The global market is witnessing key trends such as an increase in mergers and acquisitions, a rise in partnerships and collaborations, product launches and increased research and development activities. Spinal Kinetics Inc. was a privately owned manufacturer and developer of artificial cervical and lumbar discs. Orthofix International N.V. bought it in March 2018. This acquisition was made to strengthen Orthofix's orthobiologics and bio-implant product range.

MaterialsCare's 3D printers for bio-implants have been developed for vet use only. However, the company stated that they will make the technology available to humans by 2021. Technological advances have also opened up new avenues for biomaterial developers. LifeNet's patent technology for allografts Matracell is used by the majority of major bio-implant manufacturers, such as Stryker or Arthrex.

Medtronic, St Jude Medical (Abbott); Stryker, DePuy Synthes, Zimmer Biomet, Organogenesis, Inc., Arthrex, Inc., Orthofix Holdings, Inc., Cochlear Ltd., and Exactech, Inc. are some of the top companies in this market.

Bio-implant Market Report Scope

The Report Covers Certain Segments

This report provides a forecast of revenue growth at the global, regional and country level and an analysis on industry trends in each sub-segment from 2014 to 2026. Grand View Research has divided the global bio-implant market by product, material origin, end use and region.

• Product Outlook (Revenue USD Million, 2014 2026)

  • Cardiovascular Implants

    • Pacing Devices

      • Pacemaker

      • ICDs

    • Stents

  • Orthopedic Implants

    • Orthobiologics

    • Trauma Implants

    • Hip Replacements

    • Knee Replacements

  • Spinal Implants

  • Dental Implants

  • Ophthalmic Implants

  • Other

• Material Outlook (Revenue USD Million, 2014-2026)

  • Ceramics

  • Polymers

  • Alloys

  • Biomaterial Metal

• Origin Outlook (Revenue USD Million, 2014-2026)

  • Autograft

  • Allograft

  • Xenograft

  • Synthetic

• End-use Outlook (Revenue USD Million, 2014-2026)

  • Hospitals

  • Clinics

  • Specialty Centres

• Regional Outlook (Revenue USD Million, 2014-2026)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • U.K.

    • France

    • Italy

    • Spain

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • MEA

    • South Africa

    • UAE

These are the most frequently asked questions about this report

b. Global bio implant market size was USD 68,686.91 Million in 2019, and is forecast to grow to USD 72,590.27 Million in 2020.

b. Global bio implant market growth is projected to be 5.9% between 2019 and 2026, to reach USD 102,696.03 million in 2026.

b. With a 33.50% share in 2019, North America was the dominant market for bio implants. This is due to an increasing number of surgical procedures that require implants and the rising adoption of advanced technologies in various medical disciplines.

b. Medtronic, St Jude Medical (Abbott); Stryker, DePuy Synthes, Zimmer Biomet, Organogenesis, Inc., Arthrex, Inc., Orthofix Holdings, Inc., Cochlear Ltd., and Exactech, Inc. are some of the key players in the bio-implant market.

b. The key factors driving growth in the bio implant market include increased adoption of bio-implant therapies, over arthroscopy, orthopedic ailments, high geriatric populations, lifestyle changes and increasing use of cosmetic surgery.

Up Market Research published a new report titled “Bio-implant Market research report which is segmented by Material (Polymers, Alloys, Biomaterial Metal, Ceramics), by Product (Spinal, Dental, Cardiovascular), By Players/Companies increasing prevalence of cardiovascular diseases (CVD) and orthopedic ailments, large geriatric population base, lifestyle changes, rising adoption of cosmetic surgeries”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Bio-implant Market Report Segments:

The market is segmented by Material (Polymers, Alloys, Biomaterial Metal, Ceramics), by Product (Spinal, Dental, Cardiovascular).

Bio-implant Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Bio-implant Market

Overview of the regional outlook of the Bio-implant Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Bio-implant Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Bio-implant Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. Polymers

                2. Alloys

                3. Biomaterial Metal

                4. Ceramics

                1. Spinal

                2. Dental

                3. Cardiovascular

8. Market scenario by region, sub-region, and country.
9. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
10. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
11. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Bio-implant Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Bio-implant Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.